Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
September 12, 2024 06:57 ET
|
Aclarion, Inc.
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing...
Bedford Metals Provides Corporate Update on Uranium Exploration Progress
September 06, 2024 01:00 ET
|
Bedford Metals Corp.
Bedford Metals provides corporate update about their uranium exploration efforts in the Athabasca Basin.
Blackwell 3D Provides Corporate Update, Eyes Asian Market
September 03, 2024 06:00 ET
|
Blackwell 3D Construction Corp.
DUBAI, UAE, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Blackwell 3D Construction Corp. (OTC: BDCC) ("Blackwell 3D” or the "Company"), an innovative 3D house printing technology company focused on advancing...
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 28, 2024 08:34 ET
|
NurExone Biologic Inc
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 14, 2024 16:05 ET
|
GT Biopharma, Inc.
GTB-3650 TriKE® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025GTB-5550 TriKE® IND submission for treatment of B7H3 positive solid tumors expected in 1H...
GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 14, 2024 08:05 ET
|
GRI Bio, Inc.
Company focused on execution of lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) GRI-0621 interim data readout of Phase 2a biomarker study on track for Q4 2024 and...
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 01, 2024 07:30 ET
|
Arbutus Biopharma Corporation
End-of-treatment data presented at the EASL Congress from two Phase 2a clinical trials supports advancing imdusiran as a potential cornerstone in a HBV functional cure treatment regimen IM-PROVE I...
Aridis Provides Corporate Update
June 24, 2024 17:58 ET
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent...
Mise à jour corporative de Kintavar
May 29, 2024 07:43 ET
|
Kintavar Exploration inc.
MONTRÉAL, 29 mai 2024 (GLOBE NEWSWIRE) -- Kintavar Exploration Inc. (la « Société » ou « Kintavar ») (TSX-V : KTR), est heureuse de fournir une mise à jour corporative détaillant les objectifs...
Kintavar Corporate Update
May 29, 2024 07:43 ET
|
Kintavar Explorations Inc.
MONTREAL, May 29, 2024 (GLOBE NEWSWIRE) -- Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR), is pleased to provide a corporate update detailing the Corporations objectives...